Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus

…, A Carella, L Gabryelski, L Jin, JH Lin, E Emini…

Index: Lu, Zhijian; Bohn, Joann; Rano, Tom; Rutkowski, Carrie A.; Simcoe, Amy L.; Olsen, David B.; Schleif, William A.; Carella, Anthony; Gabryelski, Lori; Jin, Lixia; Lin, Jiunn H.; Emini, Emilio; Chapman, Kevin; Tata, James R. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 23 p. 5311 - 5314

Full Text: HTML

Citation Number: 6

Abstract

Efforts directed to identifying potent HIV protease inhibitors (PI) have yielded a class of compounds that are not only very active against wild-type (NL4-3) HIV virus but also very potent against a panel of PI-resistant viral isolates. Chemistry and biology are described. ... Efforts directed to identifying potent HIV protease inhibitors (PI) have yielded a class of compounds that are not only very active against wild-type (NL4-3) HIV virus but also very potent against a panel of ...